N-acetylcysteine amide, a thiol antioxidant, prevents bleomycin-induced toxicity in human alveolar basal epithelial cells (A549)

References

• Lazo JS, Chabner BA. Cancer chemotherapy and biotherapy: principles and practice. In: Chabner BA, Longo DL (eds.). Philadelphia: Lippincott-Raven, 1996. pp. 379–394.
   Google Scholar
• Hecht SM. Bleomycin: new perspectives on the mechanism of action. J Nat Prod 2000;63:158–168.
   PubMed Web of Science ®Google Scholar
• Chandler DB. Possible mechanisms of bleomycin-induced fibrosis. Clin Chest Med 1990;11:21–30.
   PubMed Web of Science ®Google Scholar
• Smith RE, Strieter RM, Phan SH, Kunkel SL. C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge. Am J Respir Cell Mol Biol 1996;15: 693–702.
   PubMed Web of Science ®Google Scholar
• Keane MP, Belperio JA, Arenberg DA, Burdick MD, Xu ZJ, Xue YY, Strieter RM. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 1999;163:5686–5692.
   PubMed Web of Science ®Google Scholar
• Parizada B, Werber MM, Nimrod A. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic Res Commun 1991;15:297–301.
   PubMed Web of Science ®Google Scholar
• Habib MP, Lackey DL, Lantz RC, Sobonya RE, Grad R, Earnest DL, Bloom JW. Vitamin A pretreatment and bleomycin induced rat lung injury. Res Commun Chem Pathol Pharmacol 1993;81:199–208.
   PubMedGoogle Scholar
• Karam H, Hurbain-Kosmath I, Housset B. Antioxidant activity in alveolar epithelial type 2 cells of rats during the development of bleomycin injury. Cell Biol Toxicol 1998; 14:13–22.
   PubMedGoogle Scholar
• Patel RB, Kotha SR, Sauers LA, Malireddy S, Gurney TO, Gupta NN, et al. Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N’-bis-2-mercaptoethyl isophthalamide. Toxicol Mech Methods 2012;22:383–396.
   PubMed Web of Science ®Google Scholar
• Cross CE, Warren D, Gerriets JE, Wilson DW, Halliwell B, Last JA. Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats. J Lab Clin Med 1985;106: 433–438.
   PubMedGoogle Scholar
• Dedon PC, Goldberg IH. Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chem Res Toxicol 1992;5:311–332.
   PubMed Web of Science ®Google Scholar
• Saleh D, Barnes PJ, Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997;155:1763–1769.
   PubMed Web of Science ®Google Scholar
• Hallgren R, Bjermer L, Lundgren R, Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis 1989;139: 373–377.
   PubMed Web of Science ®Google Scholar
• Lakari E, Soini Y, Saily M, Koistinen P, Paakko P, Kinnula VL. Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung. Am J Clin Pathol 2002;117:132–142.
   PubMedGoogle Scholar
• Galvan L, Huang CH, Prestayko AW, Stout JT, Evans JE, Crooke ST. Inhibition of bleomycin-induced DNA breakage by superoxide dismutase. Cancer Res 1981;41:5103–5106.
   PubMed Web of Science ®Google Scholar
• Cunningham ML, Ringrose PS, Lokesh BR. Inhibition of the genotoxicity of bleomycin by superoxide dismutase. Mutat Res 1984;135:199–202.
   PubMedGoogle Scholar
• Hagiwara SI, Ishii Y, Kitamura S. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med 2000;162: 225–231.
   PubMed Web of Science ®Google Scholar
• Tamagawa K, Taooka Y, Maeda A, Hiyama K, Ishioka S, Yamakido M. Inhibitory effects of a lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 2000;161:1279–1284.
   PubMed Web of Science ®Google Scholar
• Rahman I, Skwarska E, Henry M, Davis M, O’Connor CM, FitzGerald MX, et al. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic Biol Med 1999;27:60–68.
   PubMed Web of Science ®Google Scholar
• Iyer SS, Ramirez AM, Ritzenthaler JD, Torres-Gonzalez E, Roser-Page S, Mora AL, et al. Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2009;296:L37–45.
   PubMed Web of Science ®Google Scholar
• Berend N. Inhibition of bleomycin lung toxicity by N-acetyl cysteine in the rat. Pathology 1985;17:108–110.
   PubMed Web of Science ®Google Scholar
• Jamieson DD, Kerr DR, Unsworth I. Interaction of N-acetylcysteine and bleomycin on hyperbaric oxygen-induced lung damage in mice. Lung 1987;165:239–247.
   PubMed Web of Science ®Google Scholar
• Ward HE, Nicholson A, Berend N. Failure of systemic N-acetyl cysteine to protect the rat lung against bleomycin toxicity. Pathology 1987;19:358–360.
   PubMed Web of Science ®Google Scholar
• Giri SN, Hyde DM, Schiedt MJ. Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters. J Lab Clin Med 1988;111:715–724.
   PubMed Web of Science ®Google Scholar
• Shahzeidi S, Sarnstrand B, Jeffery PK, McAnulty RJ, Laurent GJ. Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur Respir J 1991;4:845–852.
   PubMed Web of Science ®Google Scholar
• Cortijo J, Cerda-Nicolas M, Serrano A, Bioque G, Estrela JM, Santangelo F, et al. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J 2001;17:1228–1235.
   PubMed Web of Science ®Google Scholar
• Behr J, Maier K, Degenkolb B, Krombach F, Vogelmeier C. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997; 156:1897–1901.
   PubMed Web of Science ®Google Scholar
• Serrano-Mollar A, Closa D, Cortijo J, Morcillo EJ, Prats N, Gironella M, et al. P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine. Thorax 2002;57:629–634.
   PubMed Web of Science ®Google Scholar
• Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, et al. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol 2003;138:1037–1048.
   PubMed Web of Science ®Google Scholar
• Behr J, Degenkolb B, Krombach F, Vogelmeier C. Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine. Eur Respir J 2002;19:906–911.
   PubMed Web of Science ®Google Scholar
• Meyer A, Buhl R, Kampf S, Magnussen H. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 1995;152:1055–1060.
   PubMed Web of Science ®Google Scholar
• Meyer A, Buhl R, Magnussen H. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 1994;7:431–436.
   PubMed Web of Science ®Google Scholar
• Cotgreave IA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1997;38:205–227.
   PubMedGoogle Scholar
• Banerjee A, Trueblood MB, Zhang X, Manda KR, Lobo P, Whitefield PD, et al. N-acetylcysteineamide (NACA) prevents inflammation and oxidative stress in animals exposed to diesel engine exhaust. Toxicol Lett 2009;187:187–193.
   PubMed Web of Science ®Google Scholar
• Carey JW, Tobwala S, Zhang X, Banerjee A, Ercal N, Pinarci E, Karacal H. N-Acetyl L-cysteine amide protects retinal pigment epithelium against methamphetamine-induced oxidative stress. J Biophys Chem 2012;3:101–110.
   Google Scholar
• Carey JW, Pinarci Y, Penugonda S, Karacal H, Ercal N. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide. Free Radical Bio Med 2011;50:722–729.
   PubMed Web of Science ®Google Scholar
• Grinberg L, Fibach E, Amer J, Atlas D. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radical Bio Med 2005;38:136–145.
   PubMed Web of Science ®Google Scholar
• Penugonda S, Ercal N. Comparative evaluation of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) on glutamate and lead-induced toxicity in CD-1 mice. Toxicol Lett 2011;201:1–7.
   PubMed Web of Science ®Google Scholar
• Schimel AM, Abraham L, Cox D, Sene A, Kraus C, Dace DS, et al. N-acetylcysteine amide (NACA) prevents retinal degeneration by up-regulating reduced glutathione production and reversing lipid peroxidation. Am J Pathol 2011;178: 2032–2043.
   PubMed Web of Science ®Google Scholar
• Zhang X, Banerjee A, Banks WA, Ercal N. N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res 2009;1275:87–95.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tobwala S, Ercal N. N-Acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice. Hum Exp Toxicol 2012;31:931–944.
   PubMedGoogle Scholar
• Offen D, Gilgun-Sherki Y, Barhum Y, Benhar M, Grinberg L, Reich R, et al. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J Neurochem 2004;89: 1241–1251.
   PubMed Web of Science ®Google Scholar
• Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999;27:612–616.
   PubMed Web of Science ®Google Scholar
• Winters RA, Zukowski J, Ercal N, Matthews RH, Spitz DR. Analysis of glutathione, glutathione disulfide, cysteine, homocysteine, and other biological thiols by high-performance liquid chromatography following derivatization by n-(1-pyrenyl)maleimide. Anal Biochem 1995;227:14–21.
   PubMed Web of Science ®Google Scholar
• Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 1993;15:353–363.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol 1984;105: 121–126.
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049–6055.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Weissler JC. Idiopathic pulmonary fibrosis: cellular and molecular pathogenesis. Am J Med Sci 1989;297:91–104.
   PubMedGoogle Scholar
• Goodman MT, Hernandez B, Wilkens LR, Lee J, Le Marchand L, Liu LQ, et al. Effects of beta-carotene and alpha-tocopherol on bleomycin-induced chromosomal damage. Cancer Epidemiol Biomarkers Prev 1998;7:113–117.
   PubMed Web of Science ®Google Scholar
• Pron G, Belehradek J Jr, Orlowski S, Mir LM. Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem Pharmacol 1994;48:301–310.
   Google Scholar
• Mastruzzo C, Crimi N, Vancheri C. Role of oxidative stress in pulmonary fibrosis. Monaldi Arch Chest Dis 2002;57: 173–176.
   PubMedGoogle Scholar
• Mata M, Ruiz A, Cerda M, Martinez-Losa M, Cortijo J, Santangelo F, et al. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Respir J 2003;22:900–905.
   PubMed Web of Science ®Google Scholar
• Crooke ST, Bradner WT. Bleomycin, a review. J Med 1976;7:333–428.
   PubMedGoogle Scholar
• White DA, Schwartzberg LS, Kris MG, Bosl GJ. Acute chest pain syndrome during bleomycin infusions. Cancer 1987;59:1582–1585.
   PubMed Web of Science ®Google Scholar
• Bowler RP, Nicks M, Warnick K, Crapo JD. Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2002;282:L719–L726.
   PubMed Web of Science ®Google Scholar
• Boyaci H, Maral H, Turan G, Basyigit I, Dillioglugil MO, Yildiz F, et al. Effects of erdosteine on bleomycin-induced lung fibrosis in rats. Mol Cell Biochem 2006;281:129–137.
   PubMed Web of Science ®Google Scholar
• Sogut S, Ozyurt H, Armutcu F, Kart L, Iraz M, Akyol O, et al. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats. Eur J Pharmacol 2004;494:213–220.
   PubMed Web of Science ®Google Scholar
• Wang HD, Yamaya M, Okinaga S, Jia YX, Kamanaka M, Takahashi H, et al. Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 2002;165:406–411.
   PubMed Web of Science ®Google Scholar
• Sayed-Ahmed MM, Mansour HH, Gharib OA, Hafez HF. Acetyl-L-carnitine modulates bleomycin-induced oxidative stress and energy depletion in lung tissues. J Egypt Natl Canc Inst 2004;16:237–243.
   PubMedGoogle Scholar
• Meister A. Glutathione metabolism. Methods Enzymol 1995;251:3–7.
   PubMed Web of Science ®Google Scholar
• Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004;134: 489–492.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Shukla GS. Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem Res 1999;24:1507–1514.
   PubMed Web of Science ®Google Scholar
• Issels RD, Nagele A, Eckert KG, Wilmanns W. Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. Biochem Pharmacol 1988;37:881–888.
   PubMed Web of Science ®Google Scholar
• Sener G, Topaloglu N, Sehirli AO, Ercan F, Gedik N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm Pharmacol Ther 2007;20:642–649.
   PubMed Web of Science ®Google Scholar
• Ali EN, Mansour SZ. Boswellic acids extract attenuates pulmonary fibrosis induced by bleomycin and oxidative stress from gamma irradiation in rats. Chin Med 2011;6:36.
   PubMed Web of Science ®Google Scholar
• Shouman SA, Abdel-Hamid MA, Hassan ZA, Mansour HH. Effects of ICRF-187 and L-carnitine on bleomycin-induced lung toxicity in rats. Saudi Pharm J 2002;10:184–189.
   Google Scholar
• Kehrer JP. Bleomycin and cyclophosphamide toxicity in mice with damaged lung tissue. Toxicol 1989;57:69–82.
   PubMed Web of Science ®Google Scholar
• Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515–540.
   PubMed Web of Science ®Google Scholar
• Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999;424:83–95.
   PubMed Web of Science ®Google Scholar
• Yildirim Z, Kotuk M, Iraz M, Kuku I, Ulu R, Armutcu F, Ozen S. Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine. Pulm Pharmacol Ther 2005;18: 367–373.
   PubMed Web of Science ®Google Scholar
• Yildirim Z, Turkoz Y, Kotuk M, Armutcu F, Gurel A, Iraz M, et al. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats. Nitric Oxide 2004; 11:156–165.
   PubMed Web of Science ®Google Scholar
• Iraz M, Erdogan H, Kotuk M, Yagmurca M, Kilic T, Ermis H, et al. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats. Pharmacol Res 2006;53:310–316.
   PubMed Web of Science ®Google Scholar
• Kara H, Karatas F, Tug T, Canatan H, Karaoglu A. Protective effect of octreotide on intra-tracheal bleomycin-induced oxidative damage in rats. Exp Toxicol Pathol 2010;62: 235–241.
   PubMed Web of Science ®Google Scholar
• Teixeira KC, Soares FS, Rocha LG, Silveira PC, Silva LA, Valenca SS, et al. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine. Pulm Pharmacol Ther 2008;21:309–316.
   PubMed Web of Science ®Google Scholar
• Erdogan H, Fadillioglu E, Kotuk M, Iraz M, Tasdemir S, Oztas Y, Yildirim Z. Effects of Ginkgo biloba on plasma oxidant injury induced by bleomycin in rats. Toxicol Ind Health 2006;22:47–52.
   PubMedGoogle Scholar
• Giri SN, Chen ZL, Younker WR, Schiedt MJ. Effects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation, and collagen content in the lungs of hamsters. Toxicol Appl Pharmacol 1983;71: 132–141.
   PubMed Web of Science ®Google Scholar
• Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973;134:707–716.
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443:787–795.
   PubMed Web of Science ®Google Scholar
• Mattson DM, Ahmad IM, Dayal D, Parsons AD, Aykin-Burns N, Li L, et al. Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism. Free Radic Biol Med 2009;46:232–237.
   PubMed Web of Science ®Google Scholar
• Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1988;1366:177–196.
   Google Scholar